Compare use cases

Drop two or three slugs into the URL — for example ?slugs=demo-mia-breast-screening,demo-idx-dr-retinopathy — or pick from the validated catalogue below.

Pick from validated:

AI imaging triage for the acute stroke pathway AI second reader for breast cancer screening Autonomous diabetic retinopathy screening in primary care Pre-operative risk-stratification model for major surgery Self-referral assistant for NHS Talking Therapies Type-2 diabetes long-term outcome predictor

Clear selection

	AI second reader for breast cancer screening United Kingdom	Autonomous diabetic retinopathy screening in primary care Netherlands	Type-2 diabetes long-term outcome predictor Netherlands
Trust badge	Validated	Validated	Validated
Evidence strength	Emerging evidence	Robust evidence	Robust evidence
Pipeline stage	Validated	Validated	Validated
Intended use	Acts as an independent second reader of screening mammograms to support the double-reading workflow and reduce reader workload without lowering cancer detection.	Provides an autonomous screening decision for more-than-mild diabetic retinopathy from retinal fundus images, referring positive cases to ophthalmology.	Estimates 5-year risk of major diabetes-related complications (cardiovascular, renal, retinal) from longitudinal primary-care records to support care-plan intensification.
Specialty	Radiology	Other	Endocrinology
Autonomy	Informs a human (advisory)	Autonomous (acts without a human)	Informs a human (advisory)
Deployment	Active deployment	Active deployment	Active deployment
EU AI Act tier	High-risk	High-risk	High-risk
EU MDR class	Class IIb	Class IIb	Not a device
CE marking	CE marked	CE marked	Not required
NICE ESF tier	Tier C — treat / diagnose / calculate risk	Tier C — treat / diagnose / calculate risk	Tier C — treat / diagnose / calculate risk
Headline metric	Sensitivity: 0.91	Sensitivity: 0.87	AUC / AUROC: 0.82
Subgroup assessed	Yes	Yes	Yes